BeOne Medicines (ONC) President discloses ADS sales and large option holdings
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Wu Xiaobin, President and COO of BeOne Medicines Ltd. (ONC), reported multiple transactions on 08/13/2025 and 08/14/2025 involving the company’s American Depositary Shares (ADS) and stock options. The filing states each ADS represents 13 ordinary shares. The reporting person sold multiple blocks of ADS under a Rule 10b5-1 trading plan adopted May 13, 2024 (amended May 14, 2025), with reported weighted-average sale prices ranging roughly from $300.00 to $308.12 across the transactions. The filing also shows a series of option grants/rights: 296,049, 352,105, 399,828, and 119,340 ordinary-share equivalents (various exercise prices and vesting schedules), and indicates direct and indirect ownership entries including shares held by the reporting person’s wife.
Positive
- Trades executed pursuant to a Rule 10b5-1 plan, providing a documented, preplanned framework for the sales
- Full disclosure of weighted-average sale prices and price ranges across transactions
- Detailed disclosure of option holdings and vesting schedules, showing continued insider exposure to equity performance
Negative
- Large insider ADS sales on 08/13/2025 and 08/14/2025 at prices roughly between $300.00 and $308.12 could be viewed negatively by some investors
- Significant reduction in direct ADS holdings recorded in the filing (multiple disposals listed)
Insights
TL;DR: Significant insider ADS sales executed under a 10b5-1 plan; large option holdings remain.
The Form 4 discloses material insider selling by the company’s President and COO across 08/13/2025 and 08/14/2025 via a Rule 10b5-1 plan, with weighted-average sale prices in the ~$300–$308 range. Sales were broken into multiple tranches and fully disclosed with price ranges. While the sales reduce reported ADS holdings, the filing also shows substantial outstanding option positions totaling several hundred thousand ordinary-share equivalents with staggered vesting schedules, which preserves ongoing insider exposure to future equity performance. For investors, this is a clear disclosure of liquidity events rather than a corporate action or financial restatement.
TL;DR: Insider complied with disclosure rules and used an established 10b5-1 plan to execute sales.
The filing explicitly notes the use of a pre-established Rule 10b5-1 trading plan (adopted May 13, 2024; amended May 14, 2025), which provides an affirmative defense for trades executed while potentially in possession of material nonpublic information. The Form 4 also provides detailed weighted-average price disclosures and identifies indirect holdings (spouse). From a governance perspective, the itemized and documented nature of these transactions aligns with best practices for transparent insider trading disclosure.
Insider Trade Summary
Net Seller: 89,794 shares ($27,347,635)
Net Sell
27 txns
Insider
Wu Xiaobin
Role
President and COO
Sold
89,794 shs ($27.35M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Share Option (Right to Buy) | 399,828 | $0.00 | -- |
| Exercise | Share Option (Right to Buy) | 119,340 | $0.00 | -- |
| Exercise | American Depositary Shares | 30,756 | $155.68 | $4.79M |
| Exercise | American Depositary Shares | 9,180 | $159.03 | $1.46M |
| Sale | American Depositary Shares | 400 | $300.8637 | $120K |
| Sale | American Depositary Shares | 5,800 | $302.0443 | $1.75M |
| Sale | American Depositary Shares | 6,965 | $303.3146 | $2.11M |
| Sale | American Depositary Shares | 500 | $304.1949 | $152K |
| Sale | American Depositary Shares | 8,522 | $305.4796 | $2.60M |
| Sale | American Depositary Shares | 12,232 | $306.2614 | $3.75M |
| Sale | American Depositary Shares | 4,917 | $307.4285 | $1.51M |
| Sale | American Depositary Shares | 600 | $308.0322 | $185K |
| Exercise | Share Option (Right to Buy) | 296,049 | $0.00 | -- |
| Exercise | Share Option (Right to Buy) | 352,105 | $0.00 | -- |
| Exercise | American Depositary Shares | 22,773 | $174.43 | $3.97M |
| Exercise | American Depositary Shares | 27,085 | $155.68 | $4.22M |
| Sale | American Depositary Shares | 8,900 | $300.3328 | $2.67M |
| Sale | American Depositary Shares | 4,500 | $301.4895 | $1.36M |
| Sale | American Depositary Shares | 5,800 | $302.4472 | $1.75M |
| Sale | American Depositary Shares | 3,517 | $303.544 | $1.07M |
| Sale | American Depositary Shares | 7,359 | $304.3738 | $2.24M |
| Sale | American Depositary Shares | 528 | $305.5914 | $161K |
| Sale | American Depositary Shares | 9,637 | $306.7442 | $2.96M |
| Sale | American Depositary Shares | 9,617 | $307.3788 | $2.96M |
| holding | Ordinary Shares | -- | -- | -- |
| holding | American Depositary Shares | -- | -- | -- |
| holding | American Depositary Shares | -- | -- | -- |
Holdings After Transaction:
Share Option (Right to Buy) — 309,881 shares (Direct);
American Depositary Shares — 30,756 shares (Direct);
Ordinary Shares — 1,228,328 shares (Direct);
American Depositary Shares — 4,000 shares (Indirect, By Wife)
Footnotes (1)
- Each American Depositary Share represents 13 Ordinary Shares. The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024, as most recently amended on May 14, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $300.00 to $300.99, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $301.00 to $301.98, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $302.00 to $302.97, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $303.00 to $303.98, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $304.00 to $304.80, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $305.17 to $306.13, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $306.19 to $307.18, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $307.20 to $307.51, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $300.44 to $301.07, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $301.52 to $302.39, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $302.79 to $303.68, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $303.85 to $304.48, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $304.95 to $305.94, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $305.95 to $306.94, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $306.95 to $307.93, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $307.99 to $308.12, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. These securities vest over a four-year period as follows: 25% on June 17, 2021 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested shares are subject to accelerated vesting upon certain termination events following a change in control. These securities vest over a four-year period as follows: 25% on the first anniversary of June 22, 2022, and the remaining in 36 successive equal monthly installments, subject to continued service. Unvested shares are subject to accelerated vesting upon certain termination events following a change in control. These securities vest over a four-year period as follows: 25% on the first anniversary of June 5, 2024, and the remaining in 36 successive equal monthly installments, subject to continued service. Unvested shares are subject to accelerated vesting upon certain termination events.
FAQ
What did Wu Xiaobin (ONC) report on Form 4?
The Form 4 reports multiple sales of BeOne ADS on 08/13/2025 and 08/14/2025 and disclosure of stock option holdings; trades were made under a Rule 10b5-1 plan.
Were the ADS sales by Wu Xiaobin preplanned?
Yes. The filing states the sales were effected pursuant to a Rule 10b5-1 trading plan adopted May 13, 2024 and most recently amended May 14, 2025.
What price range were the ADS sold at?
The filing discloses weighted-average sale prices with underlying transaction price ranges approximately between $300.00 and $308.12 across the reported sales.